PolyPid Down 19% After Study Update, Private Placement

WSJDec 24 14:58 ET

PolyPid Eyes Results From D-PLEX100 Trial in Q2 After Independent Board Gives Nod to Complete Enrollment

MT NewswiresDec 24 07:06 ET

Express News | PolyPid Ltd - 630 Patients Enrolled, Completion Expected Q1 2025, Results Q2 2025

ReutersDec 23 19:23 ET

Express News | PolyPid Announces Positive Recommendation by Dsmb to Continue Enrollment of Phase 3 Shield II Trial of D-Plex₁₀₀ to 800 Patients With a Concurrent Private Placement of up to $41 Million

ReutersDec 23 19:22 ET

PolyPid Announces Positive Recommendation by DSMB to Continue Enrollment of Phase 3 SHIELD II Trial of D-PLEX100 to 800 Patients With a Concurrent Private Placement of up to $41 Million

GlobeNewswireDec 23 19:22 ET

H.C. Wainwright Maintains PolyPid(PYPD.US) With Buy Rating, Maintains Target Price $14

Moomoo NewsDec 16 07:31 ET · Ratings